Navigation Links
Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
Date:3/12/2008

TSX: BMR

TORONTO, March 12 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a clinical oncology company specializing in the development and commercialization of cancer therapies, today announced its 2007 fourth quarter and fiscal year operational and financial results.

Operational Highlights

During the year ended December 31, 2007, the Company achieved the following steps in preparation for the upcoming multi-center Phase III trial and subsequent planned commercialization for its lead drug Neuradiab, a treatment for glioblastoma multiforme, the most deadly form of brain cancer:

- Completed development and validation of cGMP manufacturing processes

of the Neuradiab drug substance (antibody component) and final drug

product (radiolabeled antibody).

- Conducted pre-Phase III meetings with the U.S. Food and Drug

Administration (FDA) regarding the protocol and design of the Phase

III trial as well as the drug manufacturing processes.

- Entered formal contracting and approval processes with more than 30

U.S. clinical trial sites, in line with previously stated site

recruitment goals.

- Prepared and submitted the Company's drug manufacturing data package

to the FDA, subsequent to the end of the fiscal year. The submission

is currently under review. After completion of the review and

satisfactory resolution of any further requests of the FDA, if any,

Bradmer will submit a clinical update to its Investigational New Drug

(IND) application and proceed with the launch of the planned Phase

III trial.

"We have made significant progress toward the initiation of our planned multi-center Phase III trial of Neuradiab by focusing specifically on reducing risk in the critical areas of manufacturing, regulatory and clinical operations," said Alan M. Ezrin, Ph.D
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Notice of Bradmer Pharmaceuticals Conference Call
2. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
3. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
4. Bradmer announces additions to Scientific Advisory Board
5. Bradmer Medical Isotope Supply For Phase III Trial Secure
6. Bradmer to present at Rodman & Renshaw Healthcare Conference
7. Bradmer provides Phase III Neuradiab trial update and guidance
8. Bradmer announces management changes
9. NHP Announces Management Promotions
10. WellPoint Announces Appearances at Upcoming Conferences
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Lehman Brothers Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... PAYROLL FITNESS" and will provide two days of payroll education covering legislative updates, ... technology changes. The speakers, which include representatives from Ceridian, Ultimate Software, the American ...
(Date:9/2/2015)... ... September 02, 2015 , ... This Fall, as ... (BCAM), Bright Pink, a national non-profit focused on the prevention and early detection ... a campaign to educate women to be breast and ovarian self-aware and celebrate ...
(Date:9/1/2015)... ... ... men, the first thing they notice when they go to button their white collar shirt ... with a collar that doesn’t close against the skin, creating a sloppy look. Or men ... because it’s uncomfortable. Now men in suits will be able to do something about ...
(Date:9/1/2015)... ... September 01, 2015 , ... Earth Brands, ( http://www.earthbrands.com ... collection. Every customer who buys an Earth Brand shoe will be given an ... Trees for the Future, a nonprofit dedicated to planting more trees. Earth Brands ...
(Date:9/1/2015)... San Diego, CA (PRWEB) , ... September 01, 2015 , ... ... with Bellus Academy will present “The Beauty Behind the Fashion” on Thursday, Oct. ... San Diego® (FWSD), will shine the spotlight on the collaboration between fashion and professional ...
Breaking Medicine News(10 mins):Health News:23rd Annual NJ Statewide Payroll Conference in Vernon, NJ at the Minerals Hotel on October 15-16, 2015 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3
... helps reduce the risk of reactivating the hepatitis B ... for breast cancer.An estimated 12 percent // of breast ... patients are at risk of developing HBV reactivation during ... degrees of liver damage that may lead to death. ...
... Most men with prostate cancer would rather find out sooner ... tested for prostate cancer using the prostate-specific antigen test. But since ... // for doctors to know what a high reading is and ... with higher levels have to undergo repeated biopsies to determine whether ...
... disease is a genetic disease that occurs predominantly in people ... from blood vessels being blocked by red blood cells // ... High blood pressure in the lungs is known as pulmonary ... pressure measured by a cuff on your arm. Instead, pulmonary ...
... study sheds light on the theory that aging is associated ... suggest the gene responsible for shortening the ends of chromosomes ... measured the length of the end of the chromosomes, known ... random sample of families living in northern Belgium. Telomere length ...
... the University of Chicago ( an evolution specialist ), ... The consortium's research, genetically fingerprinted virus samples from several ... Kong.// ,The work provides more evidence that SARS ... suggests, that prompt control of new cases is crucial, ...
... for kids in the United Kingdom, finds a new ... preschoolers. ,The study involved 78 children who were 3 ... their total energy expenditure, along with their amount of ... were spending only about 20 to 25 minutes a ...
Cached Medicine News:Health News:Reducing The Risk Of Death In Sickle Cell Disease 2Health News:Scientists Have Traced How The SARS Virus evolved 2
(Date:9/1/2015)... --  Alpha Imaging LLC , a leading distributor of advanced medical ... that they have been awarded exclusive rights to represent the complete ... new territory supplements Alpha Imaging,s existing Shimadzu sales and service responsibilities ... , Indiana , Pennsylvania , ... West Virginia , Delaware and ...
(Date:9/1/2015)... BAKERSFIELD, Calif. , Sept. 1, 2015 /PRNewswire/ ... Chronic Care Management (CCM) and Drug Adherence m ... monitoring help automate the process of non face-to-face ... "With this new release of our apps, ... care management services along with our ONCHIT certified ...
(Date:9/1/2015)... , Sept. 1, 2015 Within ... employees, SHL Group has rapidly reached 3,000 employees ... rapid growth in the injectable drug delivery market ... A global leader in the design and ... offers innovative designs, robust manufacturing capabilities, a lean ...
Breaking Medicine Technology:Alpha Imaging Expands Shimadzu Territory 2SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2SHL Group Reaches Major Milestone of 3000 Employees 2
... WIRE)--Jun 4, 2007 - Cytogen Corporation,(NASDAQ: CYTO) ... QUADRAMET (samarium Sm-153 lexidronam injection),can be safely ... also,receiving the chemotherapy docetaxel (Taxotere(R), Sanofi-Aventis).,Clinical data ... for the treatment of prostate cancer in ...
... 2007 /PRNewswire-FirstCall/ -- VION,PHARMACEUTICALS, INC. announced that it ... the 43rd Annual Meeting of The American,Society of ... (VNP40101M) as a single agent in a Phase ... cell lung cancer. , The Phase II trial ...
Cached Medicine Technology:New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 2New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 3New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 4New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 5New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 6New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 7Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 2Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 3Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 4
... Faster speeds, highest precision, more user-friendliness and ... this is the definition of the Mastercycler ... nucleic acid research has been developing dynamically. ... of PCR Systems. To keep pace ...
... Thermal Cycler is one of the smallest ... Benefits include: Fast ramping, low cost, ... and program naming, Ready-to-go templates, interchangeable blocks. ... Biology and Diagnostic laboratories and is suitable ...
MiniCycler thermal cycler with Hot Bonnet heated lid, holds 16x0.5ml tubes...
... The DNA Engine instrument is the ... uniformity and swappable blocks ensure consistent results, ... more than just a cycler, it's a ... research needs evolve. DNA Engine thermal cycler ...
Medicine Products: